Neurotoxin Advisory Council

 

 

  • (April 2015) FDA approves an expanded indication for Botox® (onabotulinumtoxinA) for the treatment of adults with upper limb spasticity, adding two thumb muscles: flexor pollicis longus and adductor pollicis.
  • (June 2015) FDA approves an in vitro assay for establishing the potency and stability of Xeomin® (incobotulinumtoxinA)
  • (July 2015) FDA approves Dysport® (abobotulinumtoxinA) for the treatment of upper limb spasticity in adult patients to decrease the severity of increased muscle tone in elbow flexors, wrist flexors, and finger flexors.
  •  

 

Mark Hallet

CHAIR
Mark Hallett,MD (bio)
President-elect
International Federation of Clinical Neurophysiology
Bethesda, MD
Mark Hallett
 
 

 

 

  • (February 2014) Medicines and Healthcare Regulatory Products Agency (UK) approves Botox┬« (onabotulinumtoxinA) for the treatment of ankle disability due to lower limb spasticity associated with stroke in adults.
  •  

 

Alberto Albanese

Alberto Albanese, MD (bio)
Professor of Neurology
Istituto Nazionale Neurologico Carlo Besta
Università Cattolica del Sacro Cuore
Milan, Italy
Alberto Albanese, MD
 
 
Zouhair Atassi
M. Zouhair Atassi, PhD, DSc (bio)
Robert A. Welch Chair of Chemistry
Professor of Biochemistry, Molecular Biology, and Immunology
Baylor College of Medicine
Houston, Texas
 

Brashear_bio_May_2010

Allison Brashear, MD (bio)
Professor and Chair, Dept of Neurology
Wake Forest University School of Medicine
Winston-Salem, North Carolina
 
 

Michael B. Chancellor

Michael B. Chancellor, MD (bio)
Professor, Oakland University William Beaumont School of Medicine
Director of Neurology Program
Department of Urology
William Beaumont Hospital
Royal Oak, Michigan
Michael B. Chancellor, MD
 
 

J. Oliver Dolly

J. Oliver Dolly, MSc, PhD, DSc (bio)
SFI Professor of Neurotherapeutics
International Center for Neurotherapeutics
Dublin City University
Dublin, Ireland
J. Oliver Dolly, MSc, PhD, DSc
 
 

Alberto Esquenazi

Alberto Esquenazi, MD (bio)
Chair, Department of Physical Medicine and Rehabilitation
Director, Gait & Motion Analysis Laboratory
MossRehab
Albert Einstein Healthcare Network
Elkins Park, Pennsylvania
Alberto Esquenazi, MD
 
 

F. Michael Ferrante

F. Michael Ferrante, MD (bio)
Director, UCLA Pain Management Center
Professor of Clinical Anesthesiology and Medicine
University of California
Los Angeles, California
F. Michael Ferrante, MD
 
 

Deborah_Gaebler_-_picture

Deborah Gaebler-Spira, MD (bio)
Professor
Department of Physical Medicine and Rehabilitation
Department of Pediatrics
Northwestern Feinberg School of Medicine
Chicago, Illinois
 
 
H. Kerr Graham
H. Kerr Graham, MD, FRCS (Ed), FRACS (bio)
Professor of Orthopaedic Surgery
Director of the Hugh Williamson Gait Laboratory
The Royal Children's Hospital
Melbourne, Australia
 
Joseph Jankovic
Joseph Jankovic, MD (bio)
Professor of Neurology, Distinguished Chair in Movement Disorders
Director, Parkinson Disease Center and Movement Disorders Clinic
Department of Neurology
Baylor College of Medicine
Houston, Texas
 
Nathaniel Mayer
Nathaniel Mayer, MD
Emeritus Founder Director, Drucker Brain Injury Center
Director, Motor Control Analysis Laboratory
MossRehab
Albert Einstein Healthcare Network
Emeritus Professor of Physical Medicine and Rehabilitation
Temple University Health Sciences Center
Elkins Park, Pennsylvania
 

Markus Naumann

Markus Naumann, MD
Professor and Head of the Department of Neurology and Clinical Neurophysiology
Academic Hospital of the Ludwigs-Maximilians-University Munich
Klinikum Augsburg, Germany
 
Markus Naumann, MD
 

 

 
Pankaj Pasricha
Pankaj (Jay) Pasricha, MD
Chief, Division of Gastroenterology and Hepatology
Stanford University School of Medicine
Stanford, California
 

sadick_good

Neil S. Sadick, MD, FAAD, FAACS, FACP, FACPh(bio)
Clinical Professor of Dermatology.
Weill Cornell Medical College
New York, New York
 

Giampietro Schiavo

Giampietro Schiavo, PhD (bio)
Senior Group Leader
Molecular Neuropathobiology Laboratory
Cancer Research UK
London Research Institute
Lincoln's Inn Fields Laboratories
London, United Kingdom
 
 

Stephen Silberstein

Stephen D. Silberstein, MD (bio)
Professor of Neurology
Director, Jefferson Headache Center
Thomas Jefferson University
Philadelphia, Pennsylvania
 

 

 

simpson

David M. Simpson, MD(bio)
Professor of Neurology,
Mount Sinai School of Medicine
Director, Neuro-AIDS Program
Mount Sinai Medical Center
New York, New York
 
Leonard Smith
Leonard A. Smith, PhD (bio)
Scientific Consultant
Clarksburg, Maryland
 


Subscribe to our newsletter